INNOVUS PHARMACEUTICALS, INC. MAY 2013 AMENDMENT TO AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE8% Convertible Debenture • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks
THIS MAY 2013 AMENDMENT TO AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (“Amendment”) is entered into as of May 6, 2013 (the “Effective Date”), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation ("Issuer"), and Bassam Damaj ("Debenture Holder").
AMENDMENT TO QUESTCOR PHARMACEUTICALS, INC. 8% DEBENTURE8% Convertible Debenture • March 14th, 2005 • Questcor Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment (the “Amendment”) to the 8% Convertible Debenture (the “Debenture”) dated March 15, 2002 issued by Questcor Pharmaceuticals, Inc., a California corporation (the “Company”), in favor of SF Capital Partners Ltd. (the “Holder”) is made and entered into as of March 10, 2005. The Company and Holder desire to amend the Debenture as set forth below.
INNOVUS PHARMACEUTICALS, INC. AMENDMENT TO 8% CONVERTIBLE DEBENTURE8% Convertible Debenture • March 19th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks
THIS AMENDMENT TO 8% CONVERTIBLE DEBENTURE (“Amendment”) is entered into as of January 12, 2013 (the “Effective Date”), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation ("Issuer"), and [ ] ("Debenture Holder").
INNOVUS PHARMACEUTICALS, INC. AMENDMENT TO SECOND AMENDED AND RESTATED 8% CONVERTIBLE DEBENTUTRE8% Convertible Debenture • March 28th, 2014 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO SECOND AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (“Amendment”) is entered into as of February 19, 2014 (the “Effective Date’), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation (“Issuer”), and Bassam Damaj (“Debenture Holder”).
